STARMATRIX POWDER FREE LATEX EXAMINATION GLOVES, WITH PROTEIN LABELING CLAIM
K023715 · Starmatrix Sdn Bhd · LYY · Feb 4, 2003 · General Hospital
Device Facts
| Record ID | K023715 |
| Device Name | STARMATRIX POWDER FREE LATEX EXAMINATION GLOVES, WITH PROTEIN LABELING CLAIM |
| Applicant | Starmatrix Sdn Bhd |
| Product Code | LYY · General Hospital |
| Decision Date | Feb 4, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 880.6250 |
| Device Class | Class 1 |
Intended Use
This glove is disposable and intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner.
Device Story
Powder-free latex examination glove; intended for use by healthcare professionals to provide a barrier against contamination between patient and examiner. Device is disposable; worn on hands. Provides reduced protein content (50 micrograms or less of total water extractable protein per gram) to minimize potential for latex-related allergic reactions. Used in clinical settings for standard examination procedures.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
Material: Natural rubber latex. Form factor: Powder-free examination glove. Protein content: 50 micrograms or less of total water extractable protein per gram. Color: Natural. Regulatory Class: I. Product Code: LYY.
Indications for Use
Indicated for use as a disposable medical glove worn on the examiner's hand to prevent cross-contamination between patient and examiner.
Regulatory Classification
Identification
A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.
Related Devices
- K021855 — TOP GLOVE POWDERFREE LATEX EXAMINATION GLOVE WITH PROTEIN LABELLING CLAIMS (50 MICROGRAMS OR LESS) · Top Glove Sdn. Bhd. · Aug 5, 2002
- K023262 — POWDER-FREE LATEX EXAMINATION GLOVE WITH PROTEIN LABELING CLAIM (200 MICROGRAM PER GRAM OF GLOVE OR LESS) · Perusahaan Getah Asas Sdn. Bhd. · Oct 28, 2002
- K980071 — SUPERGLOVES LOW PROTEIN POWDER FREE LATEX EXAMINATION GLOVES · Supermax Latex Products Sdn. Bhd. · Mar 13, 1998
- K990539 — BRIGHTWAY BRAND LATEX EXAMINATION GLOVES (POWDER FREE) · Brightway Holdings Sdn. Bhd. · Apr 9, 1999
- K993093 — HEALTH-PLUS, SANITEX, RELIANCE (50 MICROGRAMS) · Pamitex Industries Sdn Bhd · Oct 29, 1999
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of an eagle with three heads, representing the three branches of government. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle image. The logo is simple and recognizable, and it is often used on official documents and websites related to the U.S. Department of Health and Human Services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
## FEB 0 4 2003
.Mr. Ngan Boon Seng Director STARMATRIX Sdn. Bhd. 10. Jalan SS 1/26, 47300 Petaling Jaya, Selangor, MALAYSIA
Re: K023715
Trade/Device Name: Powder Free Latex Examination Gloves, with Protein Labeling Claim. Contains 50 Micrograms or Less of Total Water Extractable Protein Per Gram, Natural Color Regulation Number: 880.6250 Regulation Name: Patient Examination Gloves Regulatory Class: I Product Code: LYY Dated: January 6, 2003 Received: January 13, 2003
Dear Mr. Seng:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 - Mr. Seng
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97), You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sases Ruas
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
{2}------------------------------------------------
## STARMATRIX SDN BHD
Company No. 479261-P 10, Jalan SS 1/26, 47300 Petaling Jaya, Selangor,Malaysia. Tel: 603-33926168 Fax: 603-33931633
## 2.0 Indications for Use Statement.
Page 5
## INDICATIONS FOR USE
| Applicant : | STARMATRIX SDN BHD |
|-------------|--------------------|
|-------------|--------------------|
510(k) Number
Device Name: on less of total Water Extractable
Indication For Use :
This glove is disposable and intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office Of Device Evaluation (ODE)
Prescription Use Per 21 CFR 801.109 Over-The-Counter : (Optional Format 1-2-96)
Olin S. Lim
OR
510(k) Number: K023715